Zobrazeno 1 - 10
of 198
pro vyhledávání: '"Meinolf, Suttorp"'
Autor:
Manuela Krumbholz, Anna Dolnik, Eric Sträng, Tabita Ghete, Sabrina Skambraks, Stephan Hutter, Alfred Simonis, Frank Stegelmann, Meinolf Suttorp, Anselm H.C. Horn, Heinrich Sticht, Torsten Haferlach, Lars Bullinger, Markus Metzler
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-9 (2024)
Abstract Chronic myeloid leukemia (CML) typically occurs in late adulthood. Pediatric CML is a rare form of leukemia. In all age groups, the characteristic genetic driver of the disease is the BCR::ABL1 fusion gene. However, additional genomic events
Externí odkaz:
https://doaj.org/article/c0002c5502d947b59c0f86f299280767
Autor:
Christian Volz, Thomas Zerjatke, Andrea Gottschalk, Sabine Semper, Meinolf Suttorp, Ingmar Glauche, Manuela Krumbholz, Markus Metzler
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Response to tyrosine kinase inhibitor (TKI) therapy in patients with chronic myeloid leukemia (CML) is monitored by quantification of BCR::ABL1 transcript levels. Milestones for assessing optimal treatment response have been defined in adult
Externí odkaz:
https://doaj.org/article/cb232df6acd6487d8b677c03dcad13e7
Autor:
Sophie Stiehler, Stephanie Sembill, Oliver Schleicher, Michaela Marx, Manfred Rauh, Manuela Krumbholz, Axel Karow, Meinolf Suttorp, Joachim Woelfle, Carlo Maj, Markus Metzler
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
In children and adolescents, impaired growth due to tyrosine kinase inhibitor therapy remains an insufficiently studied adverse effect. This study examines demographic, pharmacological, and genetic factors associated with impaired longitudinal growth
Externí odkaz:
https://doaj.org/article/1b6720258ca94a3e89023ab34242b4d8
Publikováno v:
Case Reports in Oncological Medicine, Vol 2024 (2024)
Pediatric chronic myeloid leukemia (pCML) is a rare malignancy accounting for only 2%–3% of all childhood leukemias. Due to this rarity, familiarity with pCML is limited among most pediatric practitioners, including even pediatric hemato-oncologist
Externí odkaz:
https://doaj.org/article/13145fa2657546348c0145e46df29c2f
Autor:
Yvonne Lisa Behrens, Gudrun Göhring, Laura Gaschler, Ronny Nienhold, Thea Reinkens, Elke Schirmer, Sabine Lukat, Sabine Knöß, Renate Strasser, Stephanie Sembill, Zofia Wotschofsky, Meinolf Suttorp, Manuela Krumbholz, Brigitte Schlegelberger, Markus Metzler, Axel Karow
Publikováno v:
EJC Paediatric Oncology, Vol 2, Iss , Pp 100067- (2023)
Externí odkaz:
https://doaj.org/article/54bcb69c90bd43ab9dc33c418b839f96
Autor:
Kristina Herzog, Florian Schepper, Thomas Pletschko, Jessy Herrmann, Mihaela Budich, Holger Christiansen, Meinolf Suttorp, Julia Martini
Publikováno v:
BMC Psychology, Vol 11, Iss 1, Pp 1-12 (2023)
Abstract Background This study examines the role of illness perceptions and fear of progression (FoP) in paediatric cancer patients and their parents for patient’s health-related quality of life (HRQoL), controlling for sociodemographic and medical
Externí odkaz:
https://doaj.org/article/e65b4bacbde640d98b0019951919fdda
Autor:
Yvonne Lisa Behrens, Laura Gaschler, Ronny Nienhold, Thea Reinkens, Elke Schirmer, Sabine Knöß, Renate Strasser, Stephanie Sembill, Zofia Wotschofsky, Meinolf Suttorp, Manuela Krumbholz, Brigitte Schlegelberger, Markus Metzler, Gudrun Göhring, Axel Karow
Publikováno v:
Haematologica, Vol 109, Iss 3 (2023)
Externí odkaz:
https://doaj.org/article/2991f0a209f34f849c803225ef909f31
Autor:
Oliver Schleicher, Annkathrin Horndasch, Manuela Krumbholz, Stephanie Sembill, Claudia Bremensdorfer, Desiree Grabow, Friederike Erdmann, Axel Karow, Markus Metzler, Meinolf Suttorp
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/cef6fdf2d7e14c548fc01a94f69b98f3
Autor:
Oliver Schleicher, Annkathrin Horndasch, Manuela Krumbholz, Stephanie Sembill, Claudia Bremensdorfer, Desiree Grabow, Friederike Erdmann, Axel Karow, Markus Metzler, Meinolf Suttorp
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundPediatric CML is very rare. Before the introduction of tyrosine kinase inhibitors (TKIs), allogeneic hematopoietic stem cell transplantation (HSCT) from a donor -if available- was the standard cure attempt. Data on the long-term outcome and
Externí odkaz:
https://doaj.org/article/697f592af65a4d758f03b0ba40c56f93
Autor:
Katja Hoffmann, Katja Cazemier, Christoph Baldow, Silvio Schuster, Yuri Kheifetz, Sibylle Schirm, Matthias Horn, Thomas Ernst, Constanze Volgmann, Christian Thiede, Andreas Hochhaus, Martin Bornhäuser, Meinolf Suttorp, Markus Scholz, Ingmar Glauche, Markus Loeffler, Ingo Roeder
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Individualization and patient-specific optimization of treatment is a major goal of modern health care. One way to achieve this goal is the application of high-resolution diagnostics together with the application of targeted thera
Externí odkaz:
https://doaj.org/article/9429451ad6684a6cab9bd77efd8baf6c